Isomab Shows Safe Blood Vessel Growth in CAD
August 29, 2026Pro angiogenic therapy shows safe blood vessel growth in coronary artery disease, with a systematic review of 11...
1
Speakers Announced for DIA Global Summit
September 9, 2026 2
Sandoz bets on strong growth in biosimilars market
September 8, 2026 3
Pig-to-human kidney transplant achieves a breakthrough
September 7, 2026 4
Ionis wins approval for rare brain disease
September 4, 2026 5
Akeso’s ivonescimab boosts survival in lung cancer
September 3, 2026
White House reaches deals with more pharmas
September 1, 2026
US Pharma Navigates Europe’s AI Regulatory Maze
August 31, 2026
Biotech funding returns as bar rises
August 30, 2026
ViiV gains US approval for newborn HIV treatment
August 29, 2026Isomab Shows Safe Blood Vessel Growth in CAD
August 29, 2026
ViiV gains US approval for newborn HIV treatment
By Ava Brown | August 29, 2026
Sandoz bets on strong growth in biosimilars market
September 8, 2026
Biotech funding returns as bar rises
August 30, 2026
Beyond Extravagance: A Royal Collection of Gems and Jewels
August 28, 2026
Top Places for Custom Alexandrite Jewelry in Glasgow
August 26, 2026Glasgow is home to a number of renowned jewelers, offering a variety of options for those looking to...
Unveiling the Marvel: How to Create Lab-Created Diamonds
By Maumereng | August 27, 2026
Speakers Announced for DIA Global Summit
September 9, 2026DIA Global Summit brings regulators and industry together for conversations shaping regulatory decisions with DIA and MHRA as co-hosts.
Pig-to-human kidney transplant achieves a breakthrough
September 7, 2026Pig kidney transplant achieves a breakthrough, lasting nine months without dialysis. See how this gene-modified organ bridges the gap to a human donor transplan
Ionis wins approval for rare brain disease
September 4, 2026Ionis wins approval for rare brain disease Alexander disease with antisense therapy Zanvastro providing treatment option.
Akeso’s ivonescimab boosts survival in lung cancer
September 3, 2026
PMV prepares to file first p53 cancer therapy
September 2, 2026
US Pharma Navigates Europe’s AI Regulatory Maze
August 31, 2026
Trending Post
1Speakers Announced for DIA Global Summit
September 9, 2026
2Sandoz bets on strong growth in biosimilars market
September 8, 2026
3Pig-to-human kidney transplant achieves a breakthrough
September 7, 2026
4Ionis wins approval for rare brain disease
September 4, 2026
5Akeso’s ivonescimab boosts survival in lung cancer
September 3, 2026All Post
Metabolic Markers
Speakers Announced for DIA Global Summit
DIA Global Summit brings regulators and industry together for conversations shaping regulatory decisions with DIA and MHRA as co-hosts.
Ava Brown 3 min read September 9, 2026
Cellular Autophagy
Sandoz bets on strong growth in biosimilars market
Sandoz aims to double net sales by 2035 with 100 biosimilars by 2040, capitalizing on patent expirations in the biosimilars market.
Ava Brown 3 min read September 8, 2026
Metabolic Markers
Pig-to-human kidney transplant achieves a breakthrough
Pig kidney transplant achieves a breakthrough, lasting nine months without dialysis. See how this gene-modified organ bridges the gap to a human donor transplan
Nur Aisyah 3 min read September 7, 2026
Metabolic Markers
Ionis wins approval for rare brain disease
Ionis wins approval for rare brain disease Alexander disease with antisense therapy Zanvastro providing treatment option.
Ava Brown 3 min read September 4, 2026
Metabolic Markers
Akeso’s ivonescimab boosts survival in lung cancer
Ivonescimab lung cancer study shows extended overall survival, with patients living longer than standard care, offering hope for PD‑L1‑positive cases.
Nur Aisyah 4 min read September 3, 2026
Metabolic Markers
PMV prepares to file first p53 cancer therapy
PMV Pharma prepares to file for approval of rezatopopt, the first oral p53 cancer therapy, in 2027 after successful phase 2 ovarian cancer trial.
Maya Puspitasari 3 min read September 2, 2026
Sleep Architecture
White House reaches deals with more pharmas
White House signs pricing deals with more pharmaceutical companies, including Alcon and Teva Pharma, to reduce drug prices in the US with pharma deals.
Maumereng 3 min read September 1, 2026
Metabolic Markers
US Pharma Navigates Europe’s AI Regulatory Maze
Discover how US pharmaceutical companies navigate the complex EU AI Act regulations for AI deployment in European clinical trials and compliance.
Maumereng 5 min read August 31, 2026
Cellular Autophagy
Biotech funding returns as bar rises
Biotech funding returns as bar rises. Discover how renewed confidence is driving drug development and changing the definition of value in the market.
Ava Brown 5 min read August 30, 2026
Cardiovascular Metrics
ViiV gains US approval for newborn HIV treatment
Newborn HIV treatment gets US FDA approval as ViiV's Tivicay PD becomes the first second‑gen INSTI cleared for infants 2 kg or heavier, widening options.
Ava Brown 3 min read August 29, 2026